About the Authors

Gregory A. Bird

Affiliation Taiga Biotechnologies, Inc., Aurora, Colorado, United States of America

Avital Polsky

Affiliation Charles C. Gates Center for Regenerative Medicine and Stem Cell Biology and Department of Dermatology, University of Colorado School of Medicine, Aurora, Colorado, United States of America

Patricia Estes

Affiliation Taiga Biotechnologies, Inc., Aurora, Colorado, United States of America

Teri Hanlon

Affiliation Charles C. Gates Center for Regenerative Medicine and Stem Cell Biology and Department of Dermatology, University of Colorado School of Medicine, Aurora, Colorado, United States of America

Haley Hamilton

Affiliation Charles C. Gates Center for Regenerative Medicine and Stem Cell Biology and Department of Dermatology, University of Colorado School of Medicine, Aurora, Colorado, United States of America

John J. Morton

Affiliation University of Colorado School of Medicine, Department of Medicine, Division of Medical Oncology, Aurora, Colorado, United States of America

Jonathan Gutman

Affiliation University of Colorado School of Medicine, Department of Medicine, Division of Medical Oncology, Aurora, Colorado, United States of America

Antonio Jimeno

Affiliation University of Colorado School of Medicine, Department of Medicine, Division of Medical Oncology, Aurora, Colorado, United States of America

Brian C. Turner

Contributed equally to this work with: Brian C. Turner, Yosef Refaeli

Affiliations Taiga Biotechnologies, Inc., Aurora, Colorado, United States of America, Charles C. Gates Center for Regenerative Medicine and Stem Cell Biology and Department of Dermatology, University of Colorado School of Medicine, Aurora, Colorado, United States of America

Yosef Refaeli

Contributed equally to this work with: Brian C. Turner, Yosef Refaeli

Yosef.Refaeli@UCDenver.edu

Affiliations Taiga Biotechnologies, Inc., Aurora, Colorado, United States of America, Charles C. Gates Center for Regenerative Medicine and Stem Cell Biology and Department of Dermatology, University of Colorado School of Medicine, Aurora, Colorado, United States of America

Competing Interests

Yosef Refaeli is a co-founder and equity holder at Taiga Biotechnologies, Inc. Brian C. Turner is a co-founder, equity holder and employee at Taiga Biotechnologies. Gregory A. Bird is an equity holder and employee at Taiga Biotechnologies. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.

Author Contributions

Conceived and designed the experiments: YR BT GB. Performed the experiments: YR BT GB TH HH PE AP JM. Analyzed the data: YR BT GB TH HH PE AP JM. Contributed reagents/materials/analysis tools: JG AJ. Wrote the paper: YR BT GB.